Cohort study of HCV reinfection rates after successful DAA treatment in persons who inject drugs, as reported by Clinical Care Options (CCO) at AASLD 2019
Data on HCC risk with spontaneous and NA-induced HBsAg loss as reported from AASLD 2019 by Clinical Care Options (CCO)
Data from AASLD 2019 showing the benefits of regular follow-up on HCC mortality in chronic hepatitis B as reported by Clinical Care Options (CCO)
Scoring method for identifying patients with low risk of HCC after SVR with HCV therapy as reported by Clinical Care Options from AASLD 2019.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.